Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis
Recruiting
Observational Study
Gastric Cancer
Intestinal Metaplasia
Atrophic Gastritis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,300 (estimated)
- Sponsor
- Chinese University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary objectives of this study are: * To identify clinical or histological factors associated with gastric cancer development in patients with IM and AG * To establish a machine learning algorithm for prediction of future gastric cancer risks and individual risk stratification in patient with IM and AG
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults \>= 18 years of age
* Histologically proven atrophic gastritis or intestinal metaplasia (at antrum and/or body and/or angular of stomach)
Exclusion Criteria:
\- none
Contacts